Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics

Ding, Li, Bailey, Matthew H., Porta-Pardo, Eduard, Thorsson, Vesteinn, Colaprico, Antonio, Bertrand, Denis, Gibbs, David L., Weerasinghe, Amila +751 more·2018·Cell

DOI 10.1016/j.cell.2018.03.033

Cited by (416)

Items 201–300 of 416

PertInInt: An Integrative, Analytical Approach to Rapidly Uncover Cancer Driver Genes with Perturbed Interactions and Functionalities
Shilpa N. Kobren, Bernard Chazelle, Mona Singh · 2020 · Cell Systems
Towards functional maps of non-coding variants in cancer
Yihan Wang, Gary C. Hon · 2024 · Frontiers in Genome Editing
Discovering novel driver mutations from pan-cancer analysis of mutational and gene expression profiles
Houriiyah Tegally, Kevin H. Kensler, Zahra Mungloo-Dilmohamud, Anisah W. Ghoorah, Timothy Richard Rebbeck, Shakuntala Baichoo · 2020 · PLoS ONE
Identification of molecular biomarkers associated with non-small-cell lung carcinoma (NSCLC) using whole-exome sequencing
Varsha Singh, Amit Katiyar, Prabhat Singh Malik, Sunil Kumar, Anant Mohan, Harpreet Singh, Deepali Jain · 2023 · Cancer Biomarkers
Reproducibility and Crossplatform Validation of Reverse-Phase Protein Array Data
Adam Byron · 2019 · Advances in experimental medicine and biology
Computational Approaches for Cancer-Fighting: From Gene Expression to Functional Foods
Francesco Monticolo, Maria Luisa Chiusano · 2021 · Cancers
Non-cancer-related pathogenic germline variants and expression consequences in ten-thousand cancer genomes
Zishan Wang, Xiao Fan, Yufeng Shen, Meghana S. Pagadala, Rebecca H. Signer, Kamil J. Cygan, William Guy Fairbrother, Hannah K. Carter, Wendy K. Chung, Kuan‐lin Huang · 2021 · Genome Medicine
Role of Chromatin Modifying Complexes and Therapeutic Opportunities in Bladder Cancer
Khyati A. Meghani, Lauren Folgosa Cooley, Andrea Piunti, Joshua J. Meeks · 2022 · Bladder Cancer
G-Quadruplex Matters in Tissue-Specific Tumorigenesis by BRCA1 Deficiency
Sanghyun Kim, Sohyun Hwang · 2022 · Genes
Impact of artificial intelligence on healthcare
Joyal Francis, Jithun V. Varghese, Arppana Thomas · 2023 · International Journal of Advances in Medicine
Proteomics and Precision Medicine
Chen Ding, Zhaoyu Qin, Yan Li, Wenhao Shi, Lingling Li, Dongdong Zhan, Wenjun Yang · 2019 · Small Methods
Strategies for Functional Interrogation of Big Cancer Data Using Drosophila Cancer Models
Erdem Bangi · 2020 · International Journal of Molecular Sciences
Spatial Epitope Barcoding Reveals Subclonal Tumor Patch Behaviors
Xavier Rovira Clavé, Alexandros P. Drainas, Sizun Jiang, Yunhao Bai, Maya Baron, Bokai Zhu, Maxim Markovic, Garry L. Coles, Michael Cory Bassik, Julien Sage et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Oncogenic Control of Metabolism
Natalya N. Pavlova, Craig B. Thompson · 2024 · Cold Spring Harbor Perspectives in Medicine
R -2-hydroxyglutarate-mediated inhibition of KDM4A compromises telomere integrity
Florence Couteau, Laurence M. Gagné, Karine Boulay, Philippe Rousseau, Mélissa Carbonneau, Mary E. McQuaid, Jyoti Nanda Sharma, Christina Sawchyn, Erlinda Fernández, Dagmar Glatz et al. · 2025 · Nucleic Acids Research
High mobility group protein 2 (HMGA2) is highly expressed in a broad range of benign and malignant tumors
Viktoria Chirico, Fatih Baybars Ergüven, Katharina Möller, Florian Lutz, Florian Viehweger, Martina Kluth, Claudia Hube‐Magg, Christian Bernreuther, Guido Sauter, Andreas Holger Marx et al. · 2025 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
Pan-cancer, multi-omic correlates of survival transcending tumor lineage across 11,019 patients reveal targets and pathways
Yiqun Zhang, Fengju Chen, Chad J. Creighton · 2025 · npj Precision Oncology
BCOR::CREBBP fusion in malignant neuroepithelial tumor of CNS expands the spectrum of methylation class CNS tumor with BCOR/BCOR(L1)-fusion
Azadeh Ebrahimi, Andreas Waha, Jens Schittenhelm, Georg Gohla, Martin U. Schuhmann, Torsten Pietsch · 2024 · Acta Neuropathologica Communications
Antithetical impacts of deleterious LRP1B mutations in non-squamous and squamous NSCLCs on predicting benefits from immune checkpoint inhibitor alone or with chemotherapy over chemotherapy alone: retrospective analyses of the POPLAR/OAK and CHOICE-01 trials
Jinliang Wang, Wenyong Zhou, Yu Xu, Jianchun Duan, Qiaoxia Zhou, Guoqiang Wang, Leo Li, Chunwei Xu, Wenxian Wang, Shangli Cai et al. · 2024 · Science China Life Sciences
MMR Deficiency Defines Distinct Molecular Subtype of Breast Cancer with Histone Proteomic Networks
Sean M. Hacking, Charissa J. Chou, Yiğit Baykara, Yihong Wang, Alper Uzun, Ece Dilber Gamsiz Uzun · 2023 · International Journal of Molecular Sciences
Unraveling the Drivers of Tumorigenesis in the Context of Evolution: Theoretical Models and Bioinformatics Tools
Xunuo Zhu, Wenyi Zhao, Zhan Mei Zhou, Xun Gu · 2023 · Journal of Molecular Evolution
HARNESSING THE POWER OF AI AND MACHINE LEARNING FOR NEXT-GENERATION SEQUENCING DATA ANALYSIS: A COMPREHENSIVE REVIEW OF APPLICATIONS, CHALLENGES, AND FUTURE DIRECTIONS IN PRECISION ONCOLOGY
Pedro Henrique Zeraik Viduedo, Victor César Urquiza Candeia, Victor Balceiro Legname Martins, Afrânio Côgo Destêfani, Vinícius Côgo Destefani · 2024 · Revista Ibero-Americana de Humanidades, Ciências e Educação
Systematic identification of novel cancer genes through analysis of deep shRNA perturbation screens
Hesam Montazeri, Mairene Coto‐Llerena, Gaia Bianco, Ehsan Zangene, Stephanie Taha‐Mehlitz, Viola Paradiso, Sumana Srivatsa, Antoine de Weck, Guglielmo Roma, Manuela Lanzafame et al. · 2021 · Nucleic Acids Research
Identification of prognostic values defined by copy number variation, mRNA and protein expression of LANCL2 and EGFR in glioblastoma patients
Hua Zhao, Xiuming Zhou, Jing Wang, Fanfan Chen, Chang-Peng Wu, Peng‐yu Diao, Lin-rong Cai, Lei Chen, Yanwen Xu, Jing Liu et al. · 2021 · Journal of Translational Medicine
The landscape of interactions between cancer polygenic risk scores and somatic alterations in cancer cells
Eduard Porta‐Pardo, Rosalyn W. Sayaman, Elad Ziv, Alfonso Valencia · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Multi-omics driven computational framework for cancer molecular subtype classification
Ahtisham Fazeel Abbasi, Muhammad Sajjad, Muhammad Nabeel Asim, Sebastian Vollmer, Andreas R. Dengel · 2025 · Scientific Reports
Dysbindin Domain-Containing 1 in Prostate Cancer: New Insights into Bioinformatic Validation of Molecular and Immunological Features
Van Thi Ngoc Tram, Hoang Dang Khoa Ta, Gangga Anuraga, Phan Vu Thuy Dung, Do Thi Minh Xuan, Sanskriti Dey, Chih‐Yang Wang, Yen‐Nien Liu · 2023 · International Journal of Molecular Sciences
Systematic pan-cancer analysis of RNF186 with potential implications in progression and prognosis in human cancer
Ye Hu, Nina Jiang, Xueqing Wang, Xiao Wu, Jinsuo Bo, Yining Chen, Yiyan Zeng, Xiaofan Wei, Hongquan Zhang, Man Li · 2023 · Life Sciences
Exploring racial disparities in bladder urothelial cancer: insights into survival and genetic variations
Sharafudeen Dahiru Abubakar, Zakariyya Muhammad Bello, Sufiyanu Sani Gusau, Imam Malik Kabir · 2024 · African Journal of Urology
Deciphering the Effects of the PYCR Family on Cell Function, Prognostic Value, Immune Infiltration in ccRCC and Pan-Cancer
Hongquan Chen, Qing Chen, Jinyang Chen, Yazhen Mao, Lidi Duan, Dongjie Ye, Wenxiu Cheng, Jiaxi Chen, Xinrong Gao, Renxi Lin et al. · 2024 · International Journal of Molecular Sciences
Multi-omics peripheral and core regions of cancer
Bingbo Wang, Xianan Dong, Jie Hu, Lin Gao · 2022 · npj Systems Biology and Applications
Activation of E3 ubiquitin ligase WWP2 by non‐receptor tyrosine kinase ACK1
Jun Zhu, Ziluo Peng, Xianyan Tian, Tiantian Wu, Aiqin Sun, Wannian Yang, Qiong Lin · 2023 · IUBMB Life
Pan-Cancer Pharmacogenetics: Targeted Sequencing Panels or Exome Sequencing?
Laurentijn Tilleman, Björn Heindryckx, Dieter L. D. Deforce, Filip Van Nieuwerburgh · 2020 · Pharmacogenomics
Unified views on variant impact across many diseases
Sushant Kumar, Mark Gerstein · 2023 · Trends in Genetics
Global Alliance for Genomics and Health Meets Bioconductor: Toward Reproducible and Agile Cancer Genomics at Cloud Scale
Vincent J. Carey, Marcel Ramos, Benjamin J. Stubbs, Shweta Gopaulakrishnan, Sehyun Oh, Nitesh Turaga, Levi Waldron, Martin T. Morgan · 2020 · JCO Clinical Cancer Informatics
Genetic characterisation of adult primary pleomorphic uterine rhabdomyosarcoma and comparison with uterine carcinosarcoma
Charles W. Ashley, Arnaud Da Cruz Paula, Lorenzo Ferrando, Rodrigo Gularte‐Mérida, Ana Paula Martins Sebastião, David N. Brown, Andrea M. Gazzo, Fresia G. Pareja, Anthe A. Stylianou, Nadeem R. Abu‐Rustum et al. · 2021 · Histopathology
Bioinformatic reanalysis of public proteomics data reveals that nuclear proteins are recurrent in cancer secretomes
Juliana de Morais, André Zelanis · 2021 · Traffic
OnkoRiskNET: a multicenter, interdisciplinary, telemedicine-based model to improve care for patients with a genetic tumor risk syndrome
Johanna Tecklenburg, Beate Vajen, Susanne Morlot, Petra Anders, Paula Memenga, Elena Link, Eva Baumann, Sarah Wölffling, Evelin Schröck, Anke Katharina Bergmann et al. · 2022 · BMC Health Services Research
Early contribution of germline and nevi genetic alterations to a rapidly-progressing cutaneous melanoma patient: a case report
Ana Mordoh, Juan Carlos Triviño Pardo, Ibel Carri, María Marcela Barrio, José Mordoh, Mariana Aris · 2023 · BMC Medical Genomics
Recent Approaches Encompassing the Phenotypic Cell Heterogeneity for Anticancer Drug Efficacy Evaluation
Aurimas Stulpinas, Aušra Imbrasaitė, Natalija Krestnikova, Audronė Valerija Kalvelytė · 2020 · IntechOpen eBooks
Integrating germline and somatic genetics to identify genes associated with lung cancer
Jack W. Pattee, Xiaowei Zhan, Guanghua Xiao, Wei Pan · 2019 · Genetic Epidemiology
Role of Bclaf1 in Promoting Adrenocortical Carcinoma Proliferation: A Study Combining the Use of Bioinformatics and Molecular Events
Hui Zhou, Mengchen Zou, Xinyi Ding, Fei Zou · 2021 · Cancer Management and Research
dN/dS-H, a New Test to Distinguish Different Selection Modes in Protein Evolution and Cancer Evolution
Xun Gu · 2022 · Journal of Molecular Evolution
Machine Learning and Bioinformatics Analysis for Laboratory Data in Pan‐Cancers Detection
Yin Hua Jia, Zixin Liu, Jie Fang Guo, Chengwen He, Xinru Zhou, Miao Xue, Tian Nie, Tingting Sun, Jinsong Kang, Qiong Lu et al. · 2023 · Advanced Intelligent Systems
Transcriptional profiles reveal histologic origin and prognosis across 33 The Cancer Genome Atlas tumor types
Hui Xiao, Liang Hu, Qi Tan, Jinping Jia, Ping Xie, Junai Li, Minghua Wang · 2023 · Translational Cancer Research
A multiomics approach reveals RNA dynamics promote cellular sensitivity to DNA hypomethylation
Ge, Alex Y., Arab, Abolfazl, Dai, Raymond, Navickas, Albertas, Fish, Lisa, Garcia, Kristle, Asgharian, Hosseinali, Goudreau, Jackson, Lee, Sean, Keenan, Kathryn et al. · 2024 · Scientific Reports
Role of Artificial Intelligence in Nanomedicine and Organ-specific Therapy: An Updated Review
Kuldeep Rajpoot · 2025 · Current Drug Targets
Aberrant methylation limits antitumoral inflammation in lung adenocarcinoma by restricting RIPK3 expression
Deepti Agrawal, Katarina Vizar Cisarova, Sebastian Vosberg, F. Allmendinger, Enkhtsetseg Munkhbaatar, Nadia Dandachi, Francisco José Fernández Hernández, Marta Tonietto, Vanessa Jäger, M Anton et al. · 2026 · Science Advances
Priority European strategies for sustainable access to high-quality genetic counselling in cancer: A Delphi study
J. Matt McCrary, Els Van Valckenborgh, Denis Horgan, Evgenia Aleksandrova, Ralf Christian Bargou, Regina Lohajova Behulova, Ivica Belina, Ann Liza Egesberg Bøhme, Joan Brunet, Florin Burada et al. · 2026 · European Journal of Human Genetics
Precision oncology in gynecologic cancers: molecular taxonomy, biomarker-guided therapeutics, and the challenge of therapeutic resistance
Shanza Waseem, Jun Zhan, Xue Xiao, Peng Bai · 2026 · Frontiers in Oncology
Luminal B Breast Cancer Coexpressingp62andALDH1A3Is Less Susceptible to Radiotherapy
Ayaka Ozaki, AKARI MATSUDA, Yuki Maemura, Yuna Tada, Takahiro Kasai, Yuka Nagashima, Chotaro Onaga, Yasushi Hara, Kazuki Kitabatake, Mitsutoshi Tsukimoto et al. · 2023 · Anticancer Research
Aberrations of DNA methylation in cancer
Максимова Варвара Павловна, Olga Usalka, Julia Makus, Valeriia G. Popova, Ekaterina Trapeznikova, Guzel Khayrieva, Guzel R. Sagitova, Жидкова Екатерина Михайловна, A. Yu. Bukina, Якубовская Марианна Геннадиевна et al. · 2022 · Advances in molecular oncology
Immune landscape and heterogeneity of cervical squamous cell carcinoma and adenocarcinoma
Binghan Liu, Yashi Xu, Bai Hu, Xiaole Song, Shitong Lin, Jiaxuan Wang, Lingfang Wang, Tian Chu, Ting Peng, Miaochun Xu et al. · 2024 · Aging
A comprehensive analysis of clinical and polygenic germline influences on somatic mutational burden
Kodi Taraszka, Stefan Groha, David King, Robert W. Tell, Kevin P. White, Elad Ziv, Noah Zaitlen, Alexander Gusev · 2024 · The American Journal of Human Genetics
Integrating bioinformatics and machine learning to identify AhR-related gene signatures for prognosis and tumor microenvironment modulation in melanoma
Qianru Li, Heli Li · 2025 · Frontiers in Immunology
MUC1 and MUC4 expression are inversely correlated and trigger immunological response and transport pathways in adult-type diffuse gliomas
Gabriel Cardoso Machado, Valéria Pereira Ferrer · 2025 · Computers in Biology and Medicine
Genomic Signatures of Recurrence After Resection of Early-Stage Node-Negative Colon Cancer
Daniel Aryeh Metzger, Benjamin C. Greenspun, Julianna Brouwer, Ying Li, Alessio Pigazzi, Despina Siolas, Mehraneh Dorna Jafari · 2025 · Annals of Surgical Oncology
Specific oncogene activation of the cell of origin in mucosal melanoma
Swathy Babu, Jiajia Chen, Chloé S. Baron, Kaiwen Sun, Emily J. Robitschek, Alicia M. McConnell, Constance Wu, Aikaterini Dedeilia, Moshe Sade-Feldman, Rodsy Modhurima et al. · 2025 · Nature Communications
Constructing and Visualizing Models using Mime-based Machine-learning Framework
H. B. Liu, Wei Zhang, Yihao Zhang, Xuejun Li, Siyi Wanggou · 2025 · Journal of Visualized Experiments
Overexpression of the PPAR‑γ protein in primary Ta/T1 non‑muscle‑invasive urothelial carcinoma
Shinichi S. Tanaka, Yasunori Tokuhara, Sho Hosokawa, Hiroyuki Ohsaki, Tatsuya Morinishi, Tamami Yamamoto, Norihiro Teramoto, Eiichiro Hirakawa · 2021 · Molecular and Clinical Oncology
Angiopoietin-Like Protein 2 Expression in Tumor Cells Supports Tumor-Associated Macrophage-Induced Tumor Progression in Esophageal Cancer
Taichi Horino, Haruki Horiguchi, Shinsei Yumoto, Tsuyoshi Kadomatsu, Yoshihiro Hara, Taisuke Yagi, Yoshifumi Baba, Yuji Miyamoto, Hideo Baba, Yuichi Oike · 2024 · Annals of Surgical Oncology
Proinflammatory Signaling Pathways and Genomic Signatures in Head and Neck Cancers
Zhong Chen, Ramya Viswanathan, Ethan L. Morgan, Jun Jeon, Carter Van Waes · 2021 · Springer eBooks
A data-driven pan-cancer proteogenomic analysis reveals the characteristics of human cancer protein expression
Ying Li, Clementine Xin Liu, Zhen Wang, Qiong Wu, Chulin Sha, Xiaolin Li · 2025 · iScience
Predicting and interpreting protein and phosphoprotein abundance from pan-cancer and single-cell transcriptomes
Hui-Mei Tsai, Tzu‐Hung Hsiao, Yu‐Chiao Chiu, Yufei Huang, Eric Y. Chuang, Yidong Chen · 2026 · iScience
Recurrent ZC3H18 mutations stabilize oncogenic endogenous retroviral RNA
Tanzina Tanu, Anna M. Cox, Jennifer A. Karlow, Priyanka Sharma, Kaiwen Sun, Xueyang He, Swathy Babu, Madeline K. Roelofs, Ethan Jeon, Jiajia Chen et al. · 2026 · Cell Reports
Ephexin3/ARHGEF5 Together with Cell Migration Signaling Partners within the Tumor Microenvironment Define Prognostic Transcriptional Signatures in Multiple Cancer Types
Dante Gustavo Juan-Guadarrama, Yarely Mabell Beltrán‐Navarro, Guadalupe Reyes‐Cruz, José Vázquez‐Prado · 2023 · International Journal of Molecular Sciences
Computational modeling of aging-related gene networks: a review
José Américo Nabuco Leva Ferreira de Freitas, Oliver Bischof · 2024 · Frontiers in Applied Mathematics and Statistics
Reframing Cancer as an Immunological Disorder Through Personalized Nutrition and AI Integration
Joyeta Ghosh, Asmita Roy · 2025 · Advances in computational intelligence and robotics book series
Mapping cancer gene dynamics through state-specific interactions
Adrian Maqueda Real, Laia Ollé-Monràs, Solip Park · 2025 · Cell Reports
The Pathology according to p53 Pathway
Yuichiro Hatano · 2023 · Pathobiology
Role of artificial intelligence in cancer diagnostics and therapeutics
Rahul Soloman Singh, Gladson David Masih, Rupa Joshi, Saurabh Sharma, Ashutosh Kumar Singh, Bikash Medhi · 2024 · Elsevier eBooks
Personalized prediction of anticancer potential of non-oncology drugs through learning from genome derived molecular pathways
Xiaobao Dong, Huanhuan Liu, Ting Tong, Liuxing Wu, Jianhua Wang, Tianyi You, Yongjian Wei, Xianfu Yi, Hongxi Yang, Jie Hu et al. · 2025 · npj Precision Oncology
Reproducible processing of TCGA regulatory networks
Viola Fanfani, Katherine Hoff Shutta, Panagiotis Mandros, Jonas Fischer, Enakshi Saha, Soel Micheletti, Chen Chen, Marouen Ben Guebila, Camila M. Lopes‐Ramos, John F Quackenbush · 2025 · GigaScience
A protein‐centric approach for exome variant aggregation enables sensitive association analysis with clinical outcomes
Ginny Xiaohe Li, Daniel B. Munro, Damian Fermin, Christine Vogel, Hyungwon Choi · 2020 · Human Mutation
Prediction of breast cancer proteins using molecular descriptors and artificial neural networks: a focus on cancer immunotherapy proteins, metastasis driver proteins, and RNA-binding proteins
Andrés López‐Cortés, Alejandro Cabrera‐Andrade, José M. Vázquez-Naya, Alejandro Pazos, Humberto González‐Díaz, César Paz‐y‐Miño, Santiago Xavier Guerrero, Yunierkis Pérez‐Castillo, Eduardo Tejera, Cristian Robert Munteanu · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
Development of Integrated Machine Learning and Data Science Approaches for the Prediction of Cancer Mutation and Autonomous Drug Discovery of Anti-Cancer Therapeutic Agents
Steve Agajanian · 2021 · Chapman University Digital Commons (Chapman University)
Deciphering the effects of PYCR family on cell function, prognostic value, immune infiltration in ccRCC and pan-cancer
Hongquan Chen, Qing Chen, Jinyang Chen, Yazhen Mao, Lidi Duan, Dongjie Ye, Wenxiu Cheng, Jiaxi Chen, Xinrong Gao, Renxi Lin et al. · 2024 · Research Square
NGS-based profiling of key cancer genes in Indian triple-negative breast cancer patients reinforces molecular heterogeneity of the disease
NandiniA Sahasrabuddhe, Aruna Korlimarla, Madhura Kulkarni, Vinay Kusuma, Jyothi S. Prabhu, Santosh Dixit, Chetan Deshmukh, TS Sridhar, Aditya Phatak, Chaitanyananda Koppiker · 2021 · Indian Journal of Cancer
Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cells
Federica Danzi, Giovanna Butera, Damien Sutton, Matthew D. Perricone, Yushu Hu, Adriana Celesia, Marcello Manfredi, Jessica Brandi, Narges Pourmandi, Noah S. Nelson et al. · 2025 · Cell Death and Disease
STUB1 (CHIP) – a prognostic marker in cancer
Subhajit Karmakar, Mouli Chatterjee, Malini Basu, Mrinal K. Ghosh · 2025 · Molecular Omics
Chinese pan‐cancer patient genomic characteristics: A comprehensive analysis based on the National Cancer Center–Clinical Diagnostics Knowledgebase real‐world clinical sequencing cohort
Hong-Rui Li, Shun Wang, Guo-Wei Zhao, Jiang-Tao Li, Xin Li, Bing-Ning Wang, Yi Zhang, Meng-Fei Yao, Lei Guo, Jian-Ming Ying et al. · 2026 · Interdisciplinary Medicine
Delineation of the Germline and Somatic Mutation Interaction Landscape in Triple-Negative and Non-Triple-Negative Breast Cancer
Jiande Wu, Tarun Karthik Kumar Mamidi, Lu Zhang, Chindo Hicks · 2020 · International Journal of Genomics
Development and evaluation of INT2GRATE: a platform for comprehensive assessment of the role of germline variants informed by tumor signature profile in Lynch syndrome
Raymond A. Isidro, Anu B. Chittenden, McKenzie Walker, Alison Schwartz, Diane Renee Koeller, Connor P. Hayes, Busra Unal, Monica Devi Manam, Ryan M. Buehler, Danielle K. Manning et al. · 2024 · Frontiers in Oncology
Natural Kinds as Homeorhetic Dynamic Systems
Davide Serpico, Francesco Guala · 2025 · The British Journal for the Philosophy of Science
Integrative In-Silico Analysis of Retroperitoneal Tumors in Colorectal Surgery: Advancements and Implications
Wenqing Liu, Weida Chen, M. Tang, Shibo Liu, Haicheng Gao, Chengli Miao · 2025 · Cell Biochemistry and Biophysics
Elastic Net Models Based on DNA Copy Number Variations Predicts Clinical Features, Expression Signatures, and Mutations in Lung Adenocarcinoma
Yi Xiang, Xiaohuan Zou, Huaqiu Shi, Xueming Xu, Caixia Wu, Wenjuan Zhong, Jinfeng Wang, Wenting Zhou, Xiaoli Zeng, Miao He et al. · 2021 · Frontiers in Genetics
Genetic Screening Approaches to Cancer Driver Characterization and Synthetic Lethal Target Discovery
Kristen E. Mengwasser · 2018 · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Systematic Identification of Novel Cancer Genes through Analysis of Deep shRNA Perturbation Screens
Hesam Montazeri, Mairene Coto‐Llerena, Gaia Bianco, Ehsan Zangene, Stephanie Taha‐Mehlitz, Viola Paradiso, Sumana Srivatsa, Antoine de Weck, Guglielmo Roma, Manuela Lanzafame et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
Personalized Perturbation Profiles Reveal Concordance between Autism Blood Transcriptome Datasets
Jason Laird, Alexandra Maertens · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Multimodal genomic markers predict immunotherapy response in the head and neck squamous cell carcinoma
Gaurav Kumar, Andrew P. South, Joseph Curry, Alban J. Linnenbach, Larry A. Harshyne, Adam Ertel, Paolo M. Fortina, Adam Luginbuhl · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Network-guided supervised learning on gene expression using a graph convolutional neural network
Hatairat Yingtaweesittikul, Chayaporn Suphavilai · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Applications of CRISPRi and CRISPRa in Drug Discovery
Luke A. Gilbert · 2022 · Wiley eBooks
Pan-cancer evolution signatures link clonal expansion to dynamic changes in the tumour immune microenvironment
Xinyu Yang, Wei Liu, Geoff Macintyre, Peter Van Loo, Florian M. Markowetz, Peter J. Bailey, Ke Yuan · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Deciphering the Functional Roles of Individual Cancer Alleles Across Comprehensive Cancer Genomic Studies
Jiayan Ma, Stephanie Ting, Bartholomew Tam, Timothy V. Pham, Michael M. Reich, Jill P. Mesirov, Pablo Tamayo, William Kim · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Amino acid substitutomics: profiling amino acid substitutions at proteomic scale unveils biological implication and escape mechanism in cancer
Peize Zhao, Shengzhi Lai, Shuaijian Dai, Chen Zhou, Ning Li, Weichuan Yu · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Recurrent oncogenic ZC3H18 mutations stabilize endogenous retroviral RNA
Tanzina Tanu, Anna M. Cox, Jennifer A. Karlow, Priyanka Sharma, Xueyang He, Constance Wu, Swathy Babu, Jared Brown, Kevin M. Brown, Stephen Jacob Chanock et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
A generative deep neural network for pan-digestive tract cancer survival analysis
Lekai Xu, Tianjun Lan, Yiqian Huang, Liansheng Wang, Junqi Lin, Xinpeng Song, Hui Tang, Haotian Cao, Hua Chai · 2025 · BioData Mining
Exploring the link between low germline mutational load and low breast cancer incidence: Lessons from the Xavante Indians
José Rueff, João Conde, Guilherme Castro · 2025 · Translational Oncology
LOXHD1 is an oncofusion-regulated antigen of ewing sarcoma
Tatiana Blanchard, Pouya Faridi, Chong Bing Xu, Adham Sean Bear, Reyaz ur Rasool, Grace Huang, Terry Lim, Rochelle Ayala, Khatuna Gabunia, Mei Ji et al. · 2025 · Scientific Reports
Association of DDR pathway proteins and breast cancer risk in a Pakistani population
Azhar Mehmood, Ishrat Mahjabeen, Simon Huw Reed, Rachel J. Errington, Muhammad Umar, Farrah Pervaiz, Mahmood Akhtar Kayani · 2025 · Future Oncology